Evaxion A (EVAX) EBIT (2020 - 2026)
Evaxion A (EVAX) reported EBIT of -$3.8 million for Q1 2026, up 1.27% on a YoY basis from -$3.8 million in Q1 2025, and up 5.75% quarter-over-quarter from -$4.1 million in Q4 2025.
Evaxion A (EVAX) EBIT (2020 - 2026) Analysis & Trends
Evaxion A has reported EBIT for 7 years, with the latest figure at -$3.8 million in Q1 2026.
- For the quarter ending Q1 2026, EBIT rose 1.27% year-over-year to -$3.8 million; the trailing twelve-month figure through Mar 2026 stood at -$9.2 million (up 35.31% YoY), and the FY2025 full-year result was -$9.2 million, up 37.32% from the prior year.
- EBIT for Q1 2026 stood at -$3.8 million, up from -$4.1 million in the prior quarter.
- The five-year high for EBIT was $3.0 million in Q3 2025, with the low at -$6.5 million in Q4 2022.
- Historically, EBIT has averaged -$4.4 million across 5 years, with a median of -$4.4 million in 2024.
- Annual changes were most pronounced in 2022 — EBIT decreased 23.65% — and 2025, when it surged 274.58%.
- Evaxion A's EBIT stood at -$6.5 million in 2022, then soared by 33.12% to -$4.4 million in 2023, then climbed by 7.79% to -$4.0 million in 2024, then slipped by 0.7% to -$4.1 million in 2025, then advanced by 5.75% to -$3.8 million in 2026.
- The last three EBIT figures came in at -$3.8 million (Q1 2026), -$4.1 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 642.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.82 Mn |
| Dec 31, 2025 | -4.05 Mn |
| Sep 30, 2025 | 3.02 Mn |
| Jun 30, 2025 | -4.34 Mn |
| Mar 31, 2025 | -3.87 Mn |
| Dec 31, 2024 | -4.02 Mn |
| Sep 30, 2024 | -1.73 Mn |
| Jun 30, 2024 | -4.58 Mn |
| Mar 31, 2024 | -4.40 Mn |
| Dec 31, 2023 | -4.36 Mn |
| Sep 30, 2023 | -5.76 Mn |
| Jun 30, 2023 | -5.68 Mn |
| Mar 31, 2023 | -6.53 Mn |
| Dec 31, 2022 | -6.53 Mn |
| Sep 30, 2022 | -6.08 Mn |
| Jun 30, 2022 | -6.26 Mn |
| Mar 31, 2022 | -6.40 Mn |
| Dec 31, 2021 | -7.72 Mn |
| Sep 30, 2021 | -5.91 Mn |
| Jun 30, 2021 | -7.03 Mn |